Search Results - "Verrico, Margaret"

Refine Results
  1. 1

    Fading AGNs in Poststarburst Galaxies by French, K. Decker, Earl, Nicholas, Novack, Annemarie B., Pardasani, Bhavya, Pillai, Vismaya R., Tripathi, Akshat, Verrico, Margaret E.

    Published in The Astrophysical journal (01-06-2023)
    “…The role of active galactic nuclei (AGNs) in quenching galaxies and driving the evolution from star forming to quiescence remains a key question in galaxy…”
    Get full text
    Journal Article
  2. 2

    Analysis of risk factors for adverse drug events in critically ill patients by Kane-Gill, Sandra L, Kirisci, Levent, Verrico, Margaret M, Rothschild, Jeffrey M

    Published in Critical care medicine (01-03-2012)
    “…OBJECTIVES:An evaluation of risk factors for adverse drug events in critically ill patients has not been previously studied. The purpose of this original study…”
    Get full text
    Journal Article
  3. 3

    Merger Signatures are Common, but not Universal, in Massive, Recently Quenched Galaxies at z ∼ 0.7 by Verrico, Margaret E., Setton, David J., Bezanson, Rachel, Greene, Jenny E., Suess, Katherine A., Goulding, Andy D., Spilker, Justin S., Kriek, Mariska, Feldmann, Robert, Narayanan, Desika, Donofrio, Vincenzo, Khullar, Gourav

    Published in The Astrophysical journal (01-05-2023)
    “…We present visual classifications of merger-induced tidal disturbances in 143 M * ∼ 10 11 M ⊙ post-starburst galaxies at z ∼ 0.7 identified in the SQuIGG L ⃗ E…”
    Get full text
    Journal Article
  4. 4

    A Systemwide Approach for Navigating the Dilemma of Oral Factor Xa Inhibitor Interference With Unfractionated Heparin Anti–Factor Xa Concentrations by Levito, Marissa N., Coons, James C., Verrico, Margaret M., Szymkowiak, Adrienne, Legler, Brianna, Dueweke, Eric J., Kane-Gill, Sandra L.

    Published in The Annals of pharmacotherapy (01-05-2021)
    “…Background Oral factor Xa inhibitors are known to significantly increase heparin anti-Xa concentrations, which leads to inaccuracies when monitoring…”
    Get full text
    Journal Article
  5. 5

    Comparison of Three Pharmacovigilance Algorithms in the ICU Setting: A Retrospective and Prospective Evaluation of ADRs by Kane-Gill, Sandra L., Forsberg, Elizabeth A., Verrico, Margaret M., Handler, Steven M.

    Published in Drug safety (01-08-2012)
    “…Background: Pharmacovigilance algorithms are used to assess the likelihood of adverse drug reaction (ADR) occurrence. The preferred instrument for use in the…”
    Get full text
    Journal Article
  6. 6

    Coronary Vasospasm and Atrial Fibrillation Associated with Ondansetron Therapy by Havrilla, Pamela L, Kane-Gill, Sandra L, Verrico, Margaret M, Seybert, Amy L, Reis, Steven E

    Published in The Annals of pharmacotherapy (01-03-2009)
    “…Objective: To provide further evidence of cardiovascular adverse effects of ondansetron, including new-onset atrial fibrillation, ST segment elevation, and…”
    Get full text
    Journal Article
  7. 7

    Evaluating the positive predictive values of antidote signals to detect potential adverse drug reactions (ADRs) in the medical intensive care unit (ICU) by Kane-Gill, Sandra L., Bellamy, Cassandra J., Verrico, Margaret M., Handler, Steven M., Weber, Robert J.

    Published in Pharmacoepidemiology and drug safety (01-12-2009)
    “…Purpose Signals are used to alert clinicians of potential ADRs. Positive predictive values (PPVs) of antidote signals in ICUs are unknown. The primary purpose…”
    Get full text
    Journal Article
  8. 8

    Adverse-drug-event rates for high-cost and high-use drugs in the intensive care unit by Kane-Gill, Sandra, Rea, Rhonda S, Verrico, Margaret M, Weber, Robert J

    Published in American journal of health-system pharmacy (01-10-2006)
    “…The rates of adverse drug events (ADEs) associated with high-cost and high-use drugs in the intensive care unit (ICU) were studied. This retrospective analysis…”
    Get full text
    Journal Article
  9. 9

    Effect of Drug Information Request Templates on Pharmacy Student Compliance with the Modified Systematic Approach to Answering Drug Information Questions by Lavsa, Stacey M, Corman, Shelby L, Verrico, Margaret M, Pummer, Tara L

    Published in The Annals of pharmacotherapy (01-11-2009)
    “…Background: The modified systematic approach to answering drug information questions is a technique used in drug information practice and in teaching pharmacy…”
    Get full text
    Journal Article
  10. 10

    Promethazine Adverse Events after Implementation of a Medication Shortage Interchange by Sheth, Heena S, Verrico, Margaret M, Skledar, Susan J, Towers, Adele L

    Published in The Annals of pharmacotherapy (01-02-2005)
    “…BACKGROUND: Prochlorperazine and droperidol were commonly used antiemetics at the University of Pittsburgh Medical Center– Presbyterian Hospital until a…”
    Get full text
    Journal Article
  11. 11

    Fulminant Chemical Hepatitis Possibly Associated with Donepezil and Sertraline Therapy by Verrico, Margaret M., Nace, David A., Towers, Adele L.

    “…OBJECTIVE: To describe a case of fulminant hepatitis possibly related to concomitant donepezil and seratriline therapy. PATIENT AND SETTING: An 83‐year‐old…”
    Get full text
    Journal Article
  12. 12

    Now You See It, Now You Don’t: Star Formation Truncation Precedes the Loss of Molecular Gas by ∼100 Myr in Massive Poststarburst Galaxies at z ∼ 0.6 by Bezanson, Rachel, Spilker, Justin S., Suess, Katherine A., Setton, David J., Feldmann, Robert, Greene, Jenny E., Kriek, Mariska, Narayanan, Desika, Verrico, Margaret

    Published in The Astrophysical journal (01-02-2022)
    “…We use ALMA observations of CO(2–1) in 13 massive ( M * ≳ 10 11 M ⊙ ) poststarburst galaxies at z ∼ 0.6 to constrain the molecular gas content in galaxies…”
    Get full text
    Journal Article
  13. 13

    Adverse Drug Events Involving COX-2 Inhibitors by Verrico, Margaret M, Weber, Robert J, McKaveney, Teresa P, Ansani, Nicole T, Towers, Adele L

    Published in The Annals of pharmacotherapy (01-09-2003)
    “…OBJECTIVE: To describe the types and severity of adverse drug-related events (ADEs) observed in patients receiving cyclooxygenase-2 (COX-2) inhibitors and to…”
    Get full text
    Journal Article
  14. 14

    Adverse Events Related to Lorazepam Use on Medical Floors by Sheth, Heena S., Galhotra, Sanjay, Verrico, Margaret M., Towers, Adele L., DeVita, Michael A.

    Published in Journal of patient safety (01-06-2008)
    “…Background: Lorazepam, an intermediate-acting benzodiazepine, is associated with oversedation and respiratory depression. Objectives: To evaluate lorazepam use…”
    Get full text
    Journal Article
  15. 15

    Star Formation Suppression by Tidal Removal of Cold Molecular Gas from an Intermediate-redshift Massive Post-starburst Galaxy by Spilker, Justin S., Suess, Katherine A., Setton, David J., Bezanson, Rachel, Feldmann, Robert, Greene, Jenny E., Kriek, Mariska, Lower, Sidney, Narayanan, Desika, Verrico, Margaret

    Published in Astrophysical journal. Letters (01-09-2022)
    “…Observations and simulations have demonstrated that star formation in galaxies must be actively suppressed to prevent the formation of overly massive galaxies…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Lack of tacrolimus-induced cardiomyopathy by Coley, KC, Verrico, MM, McNamara, DM, Park, SC, Cressman, MD, Branch, RA

    Published in The Annals of pharmacotherapy (01-09-2001)
    “…BACKGROUND: Hypertrophic cardiomyopathy (HCM) has been reported in pediatric transplant patients receiving tacrolimus. It is unclear whether tacrolimus is…”
    Get full text
    Journal Article
  20. 20